Social-Adaptive and psychological functioning of patients affected by Fabry disease

Journal of Inherited Metabolic Disease

Volumn 33, Issue SUPPL. 3, 2010, Pages

  Laney, Dawn Alyssia ^a   Gruskin, Daniel J ^b   Fernhoff, Paul M ^a   Cubells, Joseph F ^a   Ousley, Opal Y ^c   Hipp, Heather ^a   Mehta, Ami J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENZYME CORPORATION   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE BEHAVIOR; ADOLESCENT; ADULT; AGE; AGGRESSION; ANTISOCIAL PERSONALITY DISORDER; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CHECKLIST; DAILY LIFE ACTIVITY; DEPRESSION; FABRY DISEASE; FEMALE; FRIEND; GENETICS; HUMAN; HUMAN RELATION; IMPULSIVENESS; MALE; MENTAL HEALTH; MIDDLE AGED; PREDICTIVE VALUE; PREVALENCE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RISK FACTOR; SELF REPORT; SEX DIFFERENCE; SOCIAL ADAPTATION; SPOUSE; UNITED STATES; YOUNG ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; GEORGIA; PSYCHOLOGY;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGE FACTORS; AGGRESSION; ANTISOCIAL PERSONALITY DISORDER; ANXIETY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHECKLIST; DEPRESSION; FABRY DISEASE; FEMALE; FRIENDS; GEORGIA; HUMANS; IMPULSIVE BEHAVIOR; INTERPERSONAL RELATIONS; MALE; MENTAL HEALTH; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SELF REPORT; SEX FACTORS; SOCIAL ADJUSTMENT; SPOUSES; YOUNG ADULT;

EID: 84897922550     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-9025-6     Document Type: Article

References (46)

1. Achenbach TM, Rescorla LA (2003) Manual for the ASEBA adult forms and profiles. University of Vermont, Research Center for Children, Youth, and Families, Burlington, VT, www.aseba.org
2. Achenbach TM, Bernstein A, Dumenci L (2005) DSM-oriented scales and statistically based syndromes for ages 18 to 59: Linking taxonomic paradigms to facilitate multitaxonomic approaches. J Pers Assess 84:49-63
3. Beck M (2006) The Mainz severity score index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease. Acta Paediatr Suppl 95:43-46
4. Berenbaum SA, Bryk KK, Duck SC, Resnick SM (2004) Psychological adjustment in children and adults with congenital adrenal hyperplasia. J Pediatr 144:741-746
5. Brady R, Grabowski GA, Thadhani R (2001) Fabry disease: Review and new perspective. SynerMed Communications 1:1-8
6. Buysse CM, Raat H, Hazelzet JA et al. (2007) Long-term psychosocial outcomes in survivors of meningococcal septic shock in childhood, and in their parents. Qual Life Res 16:1567-1576
7. Carpenter RE, Loo SK, Yang M, Dang J, Smalley SL (2009) Social functioning difficulties in ADHD: association with PDD risk. Clin Child Psychol Psychiatry 14:329-344
8. Cleeland CS (2002) Pain assessment: the advantages of using pain scales in lysosomal storage diseases. Acta Paediatr Suppl 91:43-47
9. Cleeland CS, Ryan KM (1994) Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 23:129-138
10. Cole A, Lee PJ, Hughes DA, Deegan PB, Waldek S, Lachmann RH (2007) Depression in adults with Fabry disease: a common and under-diagnosed problem. J Inherit Metab Dis 30:943-951
11. Compas BE, Boyer MC, Stanger C et al. (2006) Latent variable analysis of coping, anxiety/depression, and somatic symptoms in adolescents with chronic pain. J Consult Clin Psychol 74:1132-1142
12. Cubells JF (2007) Beyond irritability and aggressive behavior: does risperidone improve adaptive behavior in autistic spectrum disorders? Curr Psychiatry Rep 9:132-133
13. Desnick R, Brady R, Barranger J et al. (2003) Fabry disease, an underrecognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338-346
14. Gold K, Pastores GM, Botteman MF et al. (2002) Quality of life of patients with Fabry disease. Qual Life Res 11:317-327
15. Gothelf D, Feinstein C, Thompson T et al. (2007) Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry 164:663-669
16. Gray D, Parker-Cohen NY, White T, Clark ST, Seiner SHAJ, McMahon WM (2001) A comparison of individual and family psychology of adolescents with chronic fatigue syndrome, rheumatoid arthritis, and mood disorders. J Dev Behav Pediatr 22:234-242
17. Grewal R (1993) Psychiatric disorders in patients with Fabry disease. Int J Psychiatry Med 23:308-312
18. Hack M, Youngstrom EA, Cartar L et al. (2004) Behavioral outcomes and evidence of psychopathology among very low birth weight infants at age 20 years. Pediatrics 114:932-940
19. Hinton VJ, Nereo NE, Fee RJ, Cyrulnik SE (2006) Social behavior problems in boys with Duchenne muscular dystrophy. J Dev Behav Pediatr 27:470-476
20. Hoffman B, Garcia de Lorenzo A, Mehta A et al. (2005) Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey). J Med Genet 42:247-252
21. Hoffman B, Beck M, Sunder Plassman G et al. (2007) Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy-A retrospective analysis from the Fabry outcome survey. Clin J Pain 23:535-542
22. Howe GW, Feinstein C, Reiss D, Molock S, Berger K (1993) Adolescent adjustment to chronic physical disorders: I. Comparing neurological and non-neurological conditions. J Child Psychol Psychiatry 34:1153-1171
23. Kampmann C, Wiethoff CM, Perrot A, Beck M, Dietz R, Osterziel KJ (2002) The heart in Anderson Fabry disease. Z Kardiol 91:786-795
24. Katon W, Russo J, Lin EH et al. (2009) Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification? Psychosom Med 50:570-579
25. Khawaja IS, Westermeyer JJ, Gajwani P, Feinstein RE (2009) Depression and coronary artery disease: the association, mechanisms, and therapeutic implications. Psychiatry (Edgmont) 6:38-51
26. Klonsky ED (2002) Valid inferences from invalid tests? Am Psychol 57:990
27. MacDermot K, Holmes A, Miners AH (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38:769-775
28. Miners A, Holmes A, Sherr L et al. (2002) Assessment of healthrelated quality-of-life in males with Anderson Fabry disease before therapeutic intervention. Qual Life Res 11:127-133
29. Muller M, Muller KM, Dascalescu A et al. (2005) Psychiatric and neuropsychological signs and symptoms in patients with Fabry disease: literature review. Fortschr Neurol Psychiatr 73:687-693
30. Mureau MAM, Slijper FME, Slob AK, Verhulst FC (1997) Psychosocial functioning of children, adolescents, and adults following hypospadias surgery: a comparative study. J Pediatr Psychol 22:371-387
31. RADAR (2009) The Fabry Registry Aggregate Data Annual Report (RADAR). Fabry registry. Genzyme Corporation, Boston, MA
32. Roza SJ, Hofstra MB, van der Ende J, Verhulst FC (2003) Stable prediction of mood and anxiety disorders based on behavioral and emotional problems in childhood: a 14-year follow-up during childhood, adolescence, and young adulthood. Am J Psychiatry 160:2116-2121
33. Sadek J, Shellhaas R, Camfield CS, Camfield PR, Burley J (2004) Psychiatric findings in four female carriers of Fabry disease. Psychiatr Genet 14:199-201
34. Sbarra DA, Rimm-Kaufman SE, Pianta RC (2002) The behavioral and emotional correlates of epilepsy in adolescence: a 7-year followup. Epilepsy Behav 3:358-367
35. Schiffmann R, Scott LJ (2002) Pathophysiology and assessment of neuropathic pain in Fabry disease. Acta Paediatr Suppl 91:48-52
36. Stavro GM, Ettenhofer ML, Nigg JT (2007) Executive functions and adaptive functioning in young adult attention-deficit/hyperactivity disorder. J Int Neuropsychol Soc 13:324-334
37. Street N, Yi MS, Bailey LA, Hopkin RJ (2006) Comparison of health related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease. Genet Med 8:346-353
38. Todd RD, Huang H, Todorov AA, Neuman RJ, ReiersenAM, Henderson CA, Reich WC (2008) Predictors of stability of attention-deficit/hyperactivity disorder subtypes fromchildhood to young adulthood. J Am Acad Child Adolesc Psychiatry 47:76-85
39. van Grootheest DS, Cath DC, Beekman AT, Boomsma DI (2007) Genetic and environmental influences on obsessive-compulsive symptoms in adults: a population-based twin-family study. Psychol Med 37:1635-1644
40. van Pareren YK, Duivenvoorden HJ, Slijper FME et al. (2005) Psychosocial functioning after discontinuation of long-term growth hormone treatment in girls with Turner syndrome. Horm Res 63:238-244
41. van Rijen EHM, Utens EMWJ, Roos-Hesselink JW et al. (2004) Medical predictors for psychopathology in adults with operated congenital heart disease. Eur Heart J 25:1605-1613
42. Väistö T, Aronen ET, Simola P, Ashorn M, Kolho KL (2009) Psychosocial symptoms and competence among adolescents with inflammatory bowel disease and their peers. Inflamm Bowel Dis 16:27-35
43. Wang RY, Lelis A, Mirocha J, Wilcox WR (2007) Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet Med 9:34-45
44. West M, LeMoine K (2007) Withdrawal of enzyme replacement therapy in Fabry disease: indirect evidence of treatment benefit? Mol Genet Metab 92:32
45. Whybra C, Kampmann C, Krummenauer F et al. (2004) The Mainz severity score index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 65:299-307
46. Wilcox WR, Oliveira JP, Hopkin RJ et al. (2008) Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab 93:112-128